Lexeo Therapeutics, Inc. (LXEO) Free cash flow 2022–2025
Lexeo Therapeutics, Inc. (LXEO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$99.0MFY2025 · since FY2022: -$55.2M → -$99.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$99.0M | -21.2% |
| FY2024 | -$81.6M | -36.9% |
| FY2023 | -$59.6M | -7.9% |
| FY2022 | -$55.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More LXEO financial trends
LXEO RevenueLXEO Net incomeLXEO Net marginLXEO Gross profitLXEO Gross marginLXEO Operating incomeLXEO Operating marginLXEO Operating cash flowLXEO Capital expendituresLXEO Return on equityLXEO Stock buybacksLXEO Dividends paidLXEO Total assetsLXEO Total liabilitiesLXEO Shareholders’ equityLXEO overview →